(Q38205174)

31 August 2017

title

The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments (English)

1 reference

31 August 2017

1 reference

4

Nicolas Wentzensen

1 reference

Magnus von Knebel Doeberitz

31 August 2017

7

object named as

Magnus von Knebel Doeberitz

1 reference

31 August 2017

Christine Bergeron

1

1 reference

31 August 2017

Guglielmo Ronco

2

1 reference

31 August 2017

Miriam Reuschenbach

3

1 reference

31 August 2017

Marc Arbyn

5

1 reference

31 August 2017

Mark Stoler

6

1 reference

31 August 2017

language of work or name

English

0 references

publication date

12 May 2014

1 reference

International Journal of Cancer

31 August 2017

published in

1 reference

31 August 2017

volume

136

1 reference

31 August 2017

issue

12

1 reference

31 August 2017

page(s)

2741-2751

1 reference

The Papanicolaou test for cervical cancer detection. A triumph and a tragedy

31 August 2017

cites work

1 reference

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

21 January 2018

1 reference

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

21 January 2018

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

Methods for HPV detection in exfoliated cell and tissue specimens

21 January 2018

1 reference

Human papillomavirus testing in the prevention of cervical cancer

21 January 2018

1 reference

Triage of HPV-positive women in cervical cancer screening

21 January 2018

1 reference

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

Updating the natural history of human papillomavirus and anogenital cancers

21 January 2018

1 reference

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

21 January 2018

1 reference

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection

21 January 2018

1 reference

Human papillomavirus and cervical cancer

21 January 2018

1 reference

Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections

21 January 2018

1 reference

A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer

21 January 2018

1 reference

Papillomaviruses in the causation of human cancers - a brief historical account

21 January 2018

1 reference

Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins

21 January 2018

1 reference

Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis.

21 January 2018

1 reference

The Pap test: George N. Papanicolaou (1883-1962). A screening test for the prevention of cancer of uterine cervix

21 January 2018

1 reference

Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

21 January 2018

1 reference

Age-specific prevalence of infection with human papillomavirus in females: a global review

21 January 2018

1 reference

Immunobiology of papillomavirus infections

21 January 2018

1 reference

The natural history of cervical HPV infection: unresolved issues

21 January 2018

1 reference

The biology and life-cycle of human papillomaviruses.

21 January 2018

1 reference

Human papillomaviruses and cervical neoplasia: a model for carcinogenesis

21 January 2018

1 reference

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

Human papillomavirus type 16 and 18 gene expression in cervical neoplasias

21 January 2018

1 reference

Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization

21 January 2018

1 reference

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

21 January 2018

1 reference

DNA damage checkpoints in stem cells, ageing and cancer.

21 January 2018

1 reference

Cellular senescence and tumor suppressor gene p16

21 January 2018

1 reference

Cellular senescence: when bad things happen to good cells

21 January 2018

1 reference

Tumor suppression by Ink4a-Arf: progress and puzzles

21 January 2018

1 reference

Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections

21 January 2018

1 reference

Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells

21 January 2018

1 reference

Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines

21 January 2018

1 reference

The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

21 January 2018

1 reference

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

21 January 2018

1 reference

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

21 January 2018

1 reference

Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix

21 January 2018

1 reference

Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia.

21 January 2018

1 reference

p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions

21 January 2018

1 reference

Using biomarkers as objective standards in the diagnosis of cervical biopsies

21 January 2018

1 reference

Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests

21 January 2018

1 reference

p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis

21 January 2018

1 reference

Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer.

21 January 2018

1 reference

p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.

21 January 2018

1 reference

p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China

21 January 2018

1 reference

p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis

21 January 2018

1 reference

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

21 January 2018

1 reference

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

21 January 2018

1 reference

Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study

21 January 2018

1 reference

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

21 January 2018

1 reference

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

21 January 2018

1 reference

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

21 January 2018

1 reference

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

21 January 2018

1 reference

Time since first sexual intercourse and the risk of cervical cancer

21 January 2018

1 reference

Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28900

1 reference

31 August 2017

1 reference